Samuel Robinson Jebas
Samuel Robinson Jebas publishes mostly in Organic Chemistry, Inorganic Chemistry and Physical and Theoretical Chemistry, on topics such as Crystal structures of chemical compounds, Synthesis and biological activity and Crystallography and molecular interactions.
- World rank
- #7,693,650 of 7,710,434 ranked researchers
- Rank in Malaysia
- #41,156 of 41,196
- Works
- 219
- Citations
- 352
- Citations per work
- 1.6
What does Samuel Robinson Jebas research?
Samuel Robinson Jebas's work is mostly in Chemistry (75%), Medicine (8%), Biochemistry, Genetics and Molecular Biology (5%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Physical Sciences17379.0%
- Chemistry16575.4%
- Materials Science83.6%
- Health Sciences188.2%
- Medicine188.2%
- Everything else177.9%
- Life Sciences114.9%
- 1Organic Chemistry36% of their works
- 2Inorganic Chemistry31% of their works
- 3Physical and Theoretical Chemistry9% of their works
- 4Oncology8% of their works
- 5Molecular Biology5% of their works
- 6Electronic, Optical and Magnetic Materials4% of their works
Research topics
- Crystal structures of chemical compounds
- Synthesis and biological activity
- Crystallography and molecular interactions
- Metal complexes synthesis and properties
- Synthesis and Characterization of Heterocyclic Compounds
- Structural and Chemical Analysis of Organic and Inorganic Compounds
- Synthesis of Organic Compounds
- Phenothiazines and Benzothiazines Synthesis and Activities
Which keywords describe Samuel Robinson Jebas's research?
The keywords of their largest research topics: Anticancer Agents, Crystal Structure Refinement, Hirshfeld Surface Analysis, Medicinal Chemistry, Heterocyclic Compounds, Tubulin Inhibitors, Synthesis and Antimicrobial.
- Biological Activities
- Oxadiazoles
- Chromones
- Biological Evaluation
- Heterocycles
- Platinum-Based Drugs
- Noncovalent Interactions
- Antimicrobial
- Tubulin Inhibitors
- Medicinal Chemistry
- Crystal Structure Refinement
- Anticancer Agents
- Hirshfeld Surface Analysis
- Heterocyclic Compounds
- Synthesis
- Molecular Crystals
- Cisplatin Resistance
- Drug Discovery
- Anticancer
- Triazines
- Flavonoids
- Thiadiazoles
- Phenothiazines
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 23 words, with their numbers
- Anticancer Agents973 topics
- Crystal Structure Refinement951 topic
- Hirshfeld Surface Analysis951 topic
- Medicinal Chemistry702 topics
- Heterocyclic Compounds591 topic
- Tubulin Inhibitors591 topic
- Synthesis454 topics
- Antimicrobial343 topics
- Molecular Crystals301 topic
- Noncovalent Interactions301 topic
- Cisplatin Resistance271 topic
- Platinum-Based Drugs271 topic
- Drug Discovery252 topics
- Heterocycles252 topics
- Anticancer232 topics
- Biological Evaluation141 topic
- Triazines141 topic
- Chromones111 topic
- Flavonoids111 topic
- Oxadiazoles111 topic
- Thiadiazoles111 topic
- Biological Activities91 topic
- Phenothiazines91 topic
Where does Samuel Robinson Jebas work?
Samuel Robinson Jebas's main affiliation in the publication record is Universiti Sains Malaysia, Malaysia.
How many publications and citations does Samuel Robinson Jebas have?
OpenAlex counts 219 works and 352 citations for Samuel Robinson Jebas, an h-index of 9, ranking #7,693,650 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Samuel Robinson Jebas. Posts are plain text and can be reported.